Ensign Peak Advisors’s CryoPort CYRX Stock Holding History

Ensign Peak Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-9,670	Closed	-$236K	–	1896
2022 Q3	$236K	Buy	9,670 +3,670	+61%	+$126K	﹤0.01%	1805
2022 Q2	$186K	Hold	6,000	–	–	﹤0.01%	1817
2022 Q1	$209K	Hold	6,000	–	–	﹤0.01%	1867
2021 Q4	$355K	Buy	+6,000	New	+$415K	﹤0.01%	1751

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Ensign Peak Advisors's CYRX Position: Q4 2022 in Review

Ensign Peak Advisors sold out of CryoPort (CYRX) in Q4 2022, closing a stake of 9,670 shares — an estimated $236K sold.

Ensign Peak Advisors first reported a position in CYRX in Q4 2021 and held it in 4 quarters. The position peaked at $355K in Q4 2021. 171 funds tracked by Wall St. Rank hold CYRX as of Q4 2022.

Ensign Peak Advisors reported no remaining CryoPort position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 9,670 CryoPort shares in Q4 2022, an estimated $236K.
Ensign Peak Advisors first reported a position in CryoPort in Q4 2021 and held it in 4 quarters.
Ensign Peak Advisors's CryoPort position peaked at $355K in Q4 2021.
171 funds tracked by Wall St. Rank held CryoPort as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.